Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
Crossref DOI link: https://doi.org/10.1007/s11523-016-0447-4
Published Online: 2016-07-13
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Scartozzi, Mario
Vincent, Loic
Chiron, Marielle
Cascinu, Stefano
Funding for this research was provided by:
Sanofi (Unrestricted grant from Sanofi, unrestricted grant from SANOFI)
License valid from 2016-07-13